News

PaxVax announced that it has entered into a definitive agreement to be acquired by Emergent BioSolutions. PaxVax is majority owned by an affiliate of Cerberus Capital Management, a…
Read More...

Perrigo Company plc announced that its Board of Directors approved a plan to separate the Company's Prescription Pharmaceuticals (Rx) business following the Company's previously…
Read More...

The U.S. Food and Drug Administration issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT)…
Read More...

Regeneron Pharmaceuticals, Inc. and bluebird bio, Inc. announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of…
Read More...

Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system…
Read More...

OvaScienceSM and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, announced…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has extended its strategic research collaboration with the Rheumatology Unit…
Read More...

Apexigen, Inc., a clinical-stage biopharmaceutical company, announced the successful completion of its Series B and Series C financings in which it raised a total of $73 million. The…
Read More...

Sotera Health announced that it has acquired New Jersey-based Gibraltar Laboratories. This acquisition expands the U.S.-based analytical testing capabilities of Sotera Health’s Nelson…
Read More...

Ambys Medicines and Takeda Pharmaceutical Company Limited announced that they have entered into a partnership to support the advancement of the Ambys platform and pipeline. “We are…
Read More...

XcellBio, a proprietary provider of primary cell control technologies for immunotherapeutic solutions announced a collaboration with Carolina BioOncology Institute (CBI) to further…
Read More...

TraceLink Inc. announced that it has joined the Irish Medicines Verification Organization (IMVO) serialization pilot study and will support a number of hospitals, pharmacies and clinics…
Read More...

Tanner Pharma Group has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney…
Read More...

Synergy Pharmaceuticals Inc. announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong (Luoxin) providing Luoxin exclusive…
Read More...

Array BioPharma Inc. announced it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for encorafenib (BRAFTOVI), in combination with…
Read More...

Antares Pharma, Inc. announced that it has entered into an agreement with Pfizer Inc. to develop a combination drug device rescue pen. This rescue pen will utilize the Antares QuickShot…
Read More...

Allergan plc  and Editas Medicine announced that Allergan's wholly-owned subsidiary, Allergan Pharmaceuticals International Limited (Allergan), has exercised its option to develop and…
Read More...

Alteogen Inc. announced that it has successfully got an approval for orphan drug designation from the US Food and Drug Administration (FDA) with one of its assets (ALT-P7) for gastric…
Read More...

Glenmark Pharmaceuticals S.A. and Harbour BioMed announced that they have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and…
Read More...

Abzena plc has entered into a master service agreement with one of America’s leading academic medical centres, NYU Langone Health (New York, US). The agreement, for protein engineering…
Read More...